Instrument Inactif

Communiqués NuVasive, Inc.

Actions

NUVA

US6707041058

Equipement, fournitures et distribution médicale

Communiqués

30/08/23	NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting	PR
02/08/23	NuVasive: Q2 Earnings Snapshot	AQ
02/08/23	NuVasive : Second Quarter 2023 Release	PU
02/08/23	NuVasive : Second Quarter 2023 Supplemental Financials	PU
02/08/23	NuVasive Announces Second Quarter 2023 Financial Results	PR
01/08/23	NuVasive : Q2 2023 NuVasive®, Inc. Earnings Conference Call	PU
24/07/23	NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results	PR
06/07/23	Eleventh Circuit Allows Equitable Tolling Of FAA's Three-month Deadline For Vacatur Of Arbitral Awards	AQ
27/05/23	NuVasive : New Financial Obligation - Form 8-K	PU
10/05/23	NuVasive : First Quarter 2023 Release	PU
10/05/23	NuVasive : First Quarter 2023 Supplemental Financials	PU
10/05/23	NuVasive: Q1 Earnings Snapshot	AQ
10/05/23	NUVASIVE INC : Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
10/05/23	NuVasive Announces First Quarter 2023 Financial Results	PR
09/05/23	NuVasive : Q1 2023 NuVasive®, Inc. Earnings Conference Call	PU
04/05/23	NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results	PR
03/05/23	NuVasive : Merger Agreement - Form 8-K	PU
03/05/23	NUVASIVE INC : Other Events (form 8-K)	AQ
27/04/23	NUVASIVE INC : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
17/04/23	NUVASIVE INC : Other Events (form 8-K)	AQ
04/04/23	NUVASIVE INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
03/04/23	NUVASIVE INC : Other Events (form 8-K)	AQ
29/03/23	NUVASIVE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA	BU
20/03/23	NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients	PR
13/03/23	NuVasive Celebrates 20-Year Milestone of the XLIF Procedure	PR